Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: A low probability of cure

Leukemia and Lymphoma

Volumn 45, Issue 7, 2004, Pages 1391-1394

  Jabbour, E ^a   Chalhoub, B ^a   Suzan, F ^a   Aloulou, S ^a   Cainap, C ^a   Toumi, N ^a   Ferme C ^a   Carde, P ^a   Ribrag, V ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Aggressive non Hodgkin's lymphoma; Elderly patients; Prognosis; Salvage chemotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE PROGRESSION; DOXORUBICIN; DRUG EVALUATION; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; HUMANS; LIFE TABLES; LYMPHOMA, HIGH-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 2542643822     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001653736     Document Type: Article

References (10)

1. Connors, J.M. and O'Reilly, S.E. (1997) "Treatment considerations in the elderly patient with lymphoma", Hematol. Oncol. Clin. North. Am., 11, 949-960.
2. Devesa, S.S. and Fears, T. (1992) "Non-Hodgkin's lymphoma time trends: United States and International data", Cancer Res., 52(Suppl 19), 5432-5440s.
3. Weisenburger, D.D. (1994) "Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic", Ann. Oncol., 5(Suppl 1), 19-24s.
4. Errante, D., Sorio, R., Zagonel, V., Carbone, A., Monfardini, S. and Tirelli, U. (1991) "A Phase II study of oralidarubicin in previously untreated elderly patients with non-Hodgkin lymphoma", Am. J. Clin. Oncol., 14, 243-245.
5. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., et al. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med., 328, 1002-1006.
6. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., et al. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma", N. Engl. J. Med., 346, 235-242.
7. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Leilie, H., Bron, D., et al. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", N. Engl. J. Med., 333, 1540-1545.
8. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group", Blood, 84, 1361-1392.
9. Sonnen, R., Schmidt, W.-P., Kuse, R. and Shmitz, N. (2002) "Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity", Br. J. Haematol., 119, 634-639.
10. Villela, L., Lopez-Guillermo, A., Montoto, S., Rives, S., Bosch, F., Perales, M., et al. (2001) "Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete remission to first-line regimens", Cancer, 91, 1557-1562.